Evidence map›Paper›PMID 36952212›Full record

SynthesisJournal of cancer survivorship : research and practice2024

A systematic review and meta-analysis of e-cigarette use among cancer survivors.

Maria A Lopez-Olivo, Justin James, Joel James, Kate J Krause, Michael Roth, Guadalupe R Palos, Hilary Ma, Alma Rodriguez, Katherine Gilmore, Paul Cinciripini and 1 more

Abstract readSystematic ReviewMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in Journal of cancer survivorship : research and practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Factors associated with health-related quality of life in survivors of childhood-onset and adult-onset cancer compared to controls.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Maria A Lopez-OlivoDepartment of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, USA. amlopezo@mdanderson.org.
Justin JamesCity University of New York School of Medicine, New York, NY, USA.
Joel JamesCity University of New York School of Medicine, New York, NY, USA.
Kate J KrauseResearch Medical Library, The University of Texas MD Anderson Cancer Center, Houston, USA.
Michael RothDepartment of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, USA.
Guadalupe R PalosOffice of Cancer Survivorship, The University of Texas MD Anderson Cancer Center, Houston, USA.
Hilary MaDepartment of General Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Alma RodriguezDepartment of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center, Lymphoma-Myeloma, Houston, USA.
Katherine GilmoreOffice of Cancer Survivorship, The University of Texas MD Anderson Cancer Center, Houston, USA.
Paul CinciripiniDepartment of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, USA.
Maria E Suarez-AlmazorDepartment of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, USA.
The University of Texas MD Anderson Cancer Center · USCity University of New York · US

Funding

Improving decision-making in patients with resectable melanoma and pre-existing autoimmune disease considering immune checkpoint inhibitionK08CA237619 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LOPEZ-OLIVO, MARIA DE LOS ANGELES · 2020 to 2024
$938k
NCI NIH HHS CA237619
6 · The paper itself

Abstract

purposeWe conducted a systematic review and meta-analysis to determine the use of e-cigarettes among cancer survivors, factors associated with their use, and prevalence of e-cigarette use as a quit attempt.

methodsWe searched five electronic databases until June 2022. Two authors independently selected studies, appraised their quality, and collected data.

resultsTwenty-three publications from eight data sources (national surveys) met our eligibility criteria. The pooled rate of lifetime e-cigarette use among cancer survivors was 15% (95% CI 6-27%); current use was 3% (95% CI 0-8%). Among survivors who currently used traditional cigarettes, 63% (95% CI 57-69%) also used e-cigarettes. The reported rates of weighted lifetime e-cigarette use differed between age groups (18-44 years, up to 46.7%; 45-64, up to 27.2%; ≥65, up to 24.8%). Nine publications reported factors associated with lifetime e-cigarette use (i.e., active use of traditional cigarettes; heavy drinking; poor mental health; younger age; being male, non-Hispanic White, or single; having less than high school education or income ≤$25,000 USD; and living in the South regions of the US or urban areas). E-cigarettes were used as a quit resource by 75% of survivors reporting dual use of electronic and traditional cigarettes (95% CI 63%, 85%).

conclusionMore than two-thirds of survivors currently using traditional cigarettes also use e-cigarettes. Higher use rates of e-cigarettes were reported among young cancer survivors compared to older survivors. Future studies are needed to assess the impact of e-cigarettes on long-term health and improve screening of smoking behaviors. IMPLICATIONS FOR CANCER SURVIVORS: Our study provides an overview of the prevalence of e-cigarette use and sociodemographic risk factors associated with e-cigarette use among cancer survivors. The findings can assist providers in supporting attempts to quit among cancer survivors.

Indexed as

Cancer SurvivorsElectronic Nicotine Delivery SystemsHumansNeoplasmsSmoking CessationVapingCancer survivorElectronic cigarettesMeta-analysisSystematic review

Identifiers

PMID36952212
OpenAlexW4360599815

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.